MedPath

The Conus Brugada Syndrome Study

Completed
Conditions
Brugada Syndrome
Registration Number
NCT06653504
Lead Sponsor
Barts & The London NHS Trust
Brief Summary

An observational, analytical, cross sectional study investigating the effects of Conus branch and Right Ventricular (RV) Branch occlusion on surface ECG and intra-cardiac electrograms in patients undergoing percutaneous coronary intervention (PCI).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Aged 18-85
  • Patients able and willing to give their written informed consent.
  • Planned PCI of a CTO of a right coronary artery
  • Planned use of an anchor balloon in the Conus branch or RV branch
Exclusion Criteria
  • Patients considered unsuitable to participate by the research team (e.g., due to medical reasons, laboratory abnormalities, or subject's unwillingness to comply with all study related procedures).
  • Patients with a pre-existing, confirmed or possible diagnosis of Brugada Syndrome
  • Marked ST elevation or J point elevation on baseline (prior to procedure) ECG in the precordial leads (V1-V3)
  • Pregnancy. This will be tested by urine HcG measurement

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ECG and/or electrogram changesDuring Procedure

Incidence of ECG changes resembling a Brugada type 1 pattern of coved ST elevation (one of the three Brugada types) specifically significant J point elevation in the precordial leads (V1-V3) and/or electrogram changes on the epicardial and/or endocardial intracardiac traces which will then be compared for differences and evidence of a transmural voltage gradient existing between them.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Barts Health NHS Trust

🇬🇧

London, United Kingdom

Barts Health NHS Trust
🇬🇧London, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.